Cancer FDA - Search News

FDA bans red dye 3

Hosted on MSN · 2d

FDA bans food dye Red 3, citing concern over cancer in some animals

The Food and Drug Administration announced Wednesday it had decided to revoke Red 3's authorization to be added to foods, over concerns about how the food coloring is linked to cancer in laboratory animals.

FDA bans Red Dye 3 over cancer concerns

The controversial artificial food dye Red 3 was banned Wednesday by the Food and Drug Administration nearly 35 years after the dye was removed from cosmetics due to cancer concerns. Dr. Eric Ascher, family medicine physician at New York City's Northwell Lenox Hill Hospital,

FOX News on MSN · 2d

FDA bans red food dye due to potential cancer risk

The U.S. Food and Drug Administration has officially banned red dye — called Red 3, or Erythrosine — from foods, dietary supplements and ingested medicines, as reported on Wednesday.

FDA, colorectal cancer

US FDA approves Amgen's colorectal cancer therapy

The U.S. Food and Drug Administration approved Amgen's combination therapy on Thursday to treat colorectal cancer in patients with a specific gene mutation.

FDA approves therapies for colorectal cancer, mantle cell lymphoma

The FDA approved two oncology regimens on Jan. 16.One is for a subset of patients with colorectal cancer and the other for treatment of patients with mantle cell lymphoma.

MarketWatch · 1d

Atara Shares Sink After FDA Stalls Cancer Treatment

Atara Biotherapeutics shares plunged after the FDA rejected its application to bring a blood cancer treatment to market. Shares of the biotechnology company were recently down 46.5% to $7.04. The stock is down more than 42.

7hon MSN

US FDA approves AstraZeneca's drug for breast cancer

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

phillyvoice.com8h

The FDA wants to limit nicotine in cigarettes — a move that could save millions of lives

Temple pulmonologist Dr. Jamie Garfield says the proposed regulation is an effective harm reduction strategy, but suggests it ...

3don MSN

To combat chronic diseases, FDA proposes putting nutrition labels on front of packages

The proposed "Nutrition info box" would show customers whether products have low, medium or high levels of saturated fat, sodium and added sugars.

4d

AbbVie secures option to license Simcere's blood cancer drug candidate

Simcere Pharmaceutical said on Monday its unit had granted U.S. drugmaker AbbVie the option to license its new blood cancer ...

4d

Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025

The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results